Delphinidin was found to interfere with the mechanisms of tau protein aggregation [17], inhibit tau hyperphosphorylation [18], and inhibit spatial memory impairment and AD hallmarks in Meynert lesioned rats in an animal model of AD [19]. Here, MAPT is linked to Alzheimer disease.